This study is looking at also assess whether psilocybin may improve quality of life in those individuals for people with Depressive Symptoms, Depression, Alzheimer Disease, or Mild Cognitive Impairment. Participants receive a study treatment and complete follow-up visits and assessments.
In Baltimore
DepressionDrugA study involving a medication or substance.From 18 Years to 85 Years
This study is looking at determine the safety and feasibility of performing psilocybin-assisted psychotherapy in patients hospitalized for treatment-resistant depression for people with Treatment Resistant Depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether questionnaires and follow-up can help people with Treatment Resistant Depression or Autism Spectrum Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Chronic Low-back Pain or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Psilocybin (drug) with placebo for people with Treatment Resistant Depression. Participants receive Psilocybin (drug) or placebo and complete study visits and assessments.
This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.
This study is looking at whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy for people with Parkinson Disease or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
